Special Masters Back Atty Fee Bid In $688M Vytorin Deal

Law360, New York (August 29, 2013, 3:04 PM EDT) -- Two special masters recommended Wednesday that a New Jersey federal court approve $140 million in attorneys’ fees sought by class counsel who settled for $688 million two securities class actions alleging Merck & Co. and its Schering-Plough subsidiary hid test results on the efficacy of their anti-cholesterol drug Vytorin.

Court-appointed special masters Stephen M. Greenberg and Jonathan J. Lerner strongly backed the attorneys’ fees and certain expense reimbursements sought by co-lead counsel for the class, saying they were reasonable, reflected the massive undertaking of five years'...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

MANSON v. SCHERING-PLOUGH CORPORATION et al


Case Number

2:08-cv-00397

Court

New Jersey

Nature of Suit

Securities/Commodities

Judge

Esther Salas

Date Filed

January 18, 2008


Case Title

GENESEE COUNTY EMPLOYEES' RETIREMENT SYSTEM v. MERCK & CO., INC. et al


Case Number

2:08-cv-02177

Court

New Jersey

Nature of Suit

Securities/Commodities

Judge

Esther Salas

Date Filed

May 5, 2008

Law Firms

Companies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.